Stock Market Today, Feb: ImmunityBio Up on Anktiva EU OK
ImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
Explore various ways to practice prudent investing that can lead to substantial financial growth. Start making smarter investment choices.
17,529 articlesImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
When newmont corporation stock dropped, investors often wonder if it’s a one-time blip or a sign of changing fundamen...
The 2.8% January 2026 COLA failed to offset rising medical expenses, as Medicare premiums swallowed most of the gain,...
London rolls out a pilot program for self-driving taxis london, pairing tech giants with the city’s complex streets. ...
A seasoned financial planner argues that a two-ETF approach can cover most retirement needs, pairing a dividend-based...
Investors brace for a potential 2026 stock market crash as volatility rises. Three defensive ETFs offer ballast with ...
A diversified ETF bundles 38 clean-energy names into a single exposure, aiming for long-term growth as policy timelin...
Rocket Lab’s stock slides after another delay to the Neutron rocket, dimming the year’s record narrative. Investors p...
American Express shares have fallen about 15% year-to-date to roughly $315 as of late February 2026, triggering a fre...
In a crowded rental market, choosing where to list can make or break how fast you find tenants. This guide breaks dow...
Industry discussions on a nationwide MLS are back in 2026 as experts weigh federation models to unify data and govern...
AutoZone beat on revenue but missed top-line estimates, while margins narrowed and shares fell. The focus: margins cr...